SG11202008233WA - Aqueous suspension pharmaceutical preparation with controlled dissolution - Google Patents
Aqueous suspension pharmaceutical preparation with controlled dissolutionInfo
- Publication number
- SG11202008233WA SG11202008233WA SG11202008233WA SG11202008233WA SG11202008233WA SG 11202008233W A SG11202008233W A SG 11202008233WA SG 11202008233W A SG11202008233W A SG 11202008233WA SG 11202008233W A SG11202008233W A SG 11202008233WA SG 11202008233W A SG11202008233W A SG 11202008233WA
- Authority
- SG
- Singapore
- Prior art keywords
- aqueous suspension
- pharmaceutical preparation
- controlled dissolution
- suspension pharmaceutical
- dissolution
- Prior art date
Links
- 239000007900 aqueous suspension Substances 0.000 title 1
- 238000004090 dissolution Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018035463 | 2018-02-28 | ||
| PCT/JP2019/007424 WO2019167978A1 (ja) | 2018-02-28 | 2019-02-27 | 溶出が制御された水性懸濁型医薬製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202008233WA true SG11202008233WA (en) | 2020-09-29 |
Family
ID=67806104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008233WA SG11202008233WA (en) | 2018-02-28 | 2019-02-27 | Aqueous suspension pharmaceutical preparation with controlled dissolution |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3760206A4 (ja) |
| JP (1) | JPWO2019167978A1 (ja) |
| CN (1) | CN111989101A (ja) |
| SG (1) | SG11202008233WA (ja) |
| WO (1) | WO2019167978A1 (ja) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2800953B2 (ja) | 1990-07-06 | 1998-09-21 | 住友製薬株式会社 | 新規なイミド誘導体 |
| ATE543817T1 (de) | 2003-07-29 | 2012-02-15 | Dainippon Sumitomo Pharma Co | Verfahren zur herstellung einer imidverbindung |
| DK1884242T3 (da) | 2005-05-26 | 2013-05-06 | Dainippon Sumitomo Pharma Co | Farmaceutisk sammensætning omfattende lurasidon |
| CN101198331B (zh) | 2005-06-13 | 2012-05-02 | 大日本住友制药株式会社 | 增溶化制剂 |
| CN107595771A (zh) * | 2010-10-18 | 2018-01-19 | 大日本住友制药株式会社 | 注射用缓释制剂 |
| CN104606133A (zh) * | 2015-01-07 | 2015-05-13 | 万特制药(海南)有限公司 | 鲁拉西酮口服混悬液及其制备方法 |
| JP2018090490A (ja) * | 2015-03-31 | 2018-06-14 | アステラス製薬株式会社 | ミラベグロン含有医薬組成物 |
| CN104983679A (zh) * | 2015-06-24 | 2015-10-21 | 万特制药(海南)有限公司 | 一种含有鲁拉西酮的缓释混悬剂及其制备方法 |
| US20170196802A1 (en) * | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long Acting Injectable Formulations |
| JPWO2018043613A1 (ja) * | 2016-08-31 | 2019-06-24 | 大日本住友製薬株式会社 | 水性懸濁型製剤 |
-
2019
- 2019-02-27 JP JP2020503544A patent/JPWO2019167978A1/ja not_active Withdrawn
- 2019-02-27 EP EP19760568.6A patent/EP3760206A4/en not_active Withdrawn
- 2019-02-27 WO PCT/JP2019/007424 patent/WO2019167978A1/ja unknown
- 2019-02-27 SG SG11202008233WA patent/SG11202008233WA/en unknown
- 2019-02-27 CN CN201980028687.0A patent/CN111989101A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2019167978A1 (ja) | 2021-02-04 |
| EP3760206A1 (en) | 2021-01-06 |
| CN111989101A (zh) | 2020-11-24 |
| WO2019167978A1 (ja) | 2019-09-06 |
| EP3760206A4 (en) | 2021-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201804534B (en) | AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-l-L1 ANTIBODY AVELUMAB | |
| HK1255566A1 (zh) | 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用 | |
| ZA201808476B (en) | Stable liquid pharmaceutical preparation | |
| HK1251546A1 (zh) | S-氯胺酮的(s)-csa鹽、s-氯胺酮的(r)-csa鹽和用於製備s-氯胺酮的方法 | |
| HK1244689A1 (zh) | 水性眼科組合物 | |
| EP3679945A4 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION | |
| DK3305785T3 (da) | Pyrido[3,4-d]pyrimidinderivat og farmaceutisk acceptabelt salt deraf | |
| PT3580219T (pt) | Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam | |
| PL3452075T3 (pl) | Oftalmiczna kompozycja farmaceutyczna | |
| IL275484A (en) | W/O/W microemulsions for ophthalmic administration | |
| EP3384773A4 (en) | AQUEOUS AGROCHEMICAL SUSPENSION COMPOSITION AND DISPERSING METHOD THEREFOR | |
| EP3384772A4 (en) | AGROCHEMICAL COMPOSITION IN AQUEOUS SUSPENSION | |
| IL256339A (en) | Result of pyrazole or its pharmacy salt | |
| HK1253288A1 (zh) | 用於製備水性物質的球形膠囊的方法和通過所述方法獲得的膠囊 | |
| EP3305294A4 (en) | AQUEOUS MEDICINE | |
| IL282343A (en) | soluble medicinal compounds | |
| EP3508203A4 (en) | PRODUCTION OF AN AQUEOUS SUSPENSION | |
| GB201507031D0 (en) | New pharmaceutical salt forms | |
| SG11202008204QA (en) | Aqueous suspension pharmaceutical preparation | |
| EP3305295A4 (en) | AQUEOUS MEDICINE | |
| SG11202008233WA (en) | Aqueous suspension pharmaceutical preparation with controlled dissolution | |
| ZA202006346B (en) | Pharmaceutical preparation | |
| IL272366A (en) | Adamantylmethylamine derivatives and their uses as a pharmaceutical preparation | |
| EP3251695A4 (en) | Aqueous preparation for external use | |
| GB201813579D0 (en) | Aqueous solution |